Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cipla
Chubb
Argus Health
Accenture
Citi
Farmers Insurance
UBS
Moodys
Dow

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,725,439

« Back to Dashboard

Summary for Patent: 4,725,439

Title: Transdermal drug delivery device
Abstract:A medical device for the transdermal delivery of an active agent through sensitive intact skin is provided. The device comprises a matrix containing the drug having reinforcing means, preferably in the form of a fabric, embedded in the upper surface of the matrix. The matrix is formed of an agent permeable material which is tacky but does not adhesively bond to the skin. The device is sufficiently flexible and deformable that the combination of tackiness, flexibility, and deformation permits the device to be maintained in agent transmitting relationship upon skin at such sensitive areas as the scrotum, labia, breast, or penis, for example. In certain embodiments, the skin distal surface is provided with a layer of an agent impermeable material to reduce transfer of the agent from the patient to others.
Inventor(s): Campbell; Patricia S. (Palo Alto, CA), Eckenhoff; James B. (Los Altos, CA), Place; Virgil A. (Kawaihae, HI)
Assignee: ALZA Corporation (Palo Alto, CA)
Application Number:06/818,561
Patent Claim Types:
see list of patent claims
Device; Composition; Use;

No matches for this query

International Patent Family for Patent: 4,725,439

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada1257819► Subscribe
Germany3523065► Subscribe
Germany3687067► Subscribe
European Patent Office0232580► Subscribe
Spain296615► Subscribe
Spain556380► Subscribe
Spain8706455► Subscribe
France2571623► Subscribe
United Kingdom2161073► Subscribe
United Kingdom2185187► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Argus Health
McKesson
McKinsey
Fish and Richardson
Accenture
AstraZeneca
Merck
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot